1-4 of 4
Katia BB Pagnano
Close
Sort by
Journal Articles

Clinical Characteristics and Outcome of 104 Patients with Gastric Diffuse B-Cell Non-Hodgkin Lymphoma (DLBCL) a Multicenter Study

Marcia T Delamain, MD, Eliana Cristina Martins Miranda, PhD, Maria Gomes da Silva, MDPhD, Joana Desterro, MD, Merli Francesco, MD, Carlos Chiattone, MD PhD, Stefano Luminari, MD, Katia BB Pagnano, Carmino Antonio De Souza, MD PhD, Massimo Federico
Journal: Blood
Blood (2015) 126 (23): 5032.
https://doi.org/10.1182/blood.V126.23.5032.5032
Published: 2015
Journal Articles

ΔNp73/TAp73 Expression Ratio Is Associated with Poor Outcome in Acute Promyelocytic Leukemia,

Antonio R Lucena-Araujo, Alexandre Krause, Rafael Henriques Jacomo, Priscila S Scheucher, Ph.D, Guilherme A dos Santos, Helder H Paiva, Patricia V Palma, Raul AM Melo, Rosane Bittencourt, MD, Ricardo Pasquini, MD, PhD, Katia BB Pagnano, Evandro M. Fagundes, Maria L. Chauffaille, PhD, Carlos S Chiattone, Robert E. Gallagher, MD, Bob Lowenberg, MD, PhD, Raul Ribeiro, MD, Francesco Lo-Coco, MD, Miguel A. Sanz, MD, PhD, Roberto P. Falcao, MD, PhD, Eduardo M Rego, MD
Journal: Blood
Blood (2011) 118 (21): 3536.
https://doi.org/10.1182/blood.V118.21.3536.3536
Published: 2011
Journal Articles

Improving the Treatment Outcome of Acute Promyelocytic Leukemia in Developing Countries through International Cooperative Network. Report On the International Consortium On Acute Promyelocytic Leukemia Study Group.

Eduardo M Rego, Haesook T. Kim, Guillermo J. Ruiz-Arguelles, Rosario Uriarte, Rafael H Jacomo, Homero Gutiérrez-Aguirre, Raul AM Melo, Rosane Bittencourt, Ricardo Pasquini, Katia BB Pagnano, Evandro M Fagundes, Maria LF Chauffaille de Lourdes, Carlos Chiattone, Lem Martinez, Luis A Meillon, David Gomez-Almaguer, Hau C. Kwaan, Javier Garces-Eisele, Robert E Gallagher, Charlotte M Niemeyer, Bob Lowenberg, Raul C Ribeiro, Francesco Lo-Coco, Miguel A Sanz
Journal: Blood
Blood (2009) 114 (22): 6.
https://doi.org/10.1182/blood.V114.22.6.6
Published: 2009
Journal Articles

Impact of Imatinib Dose Escalation in Chronic Myeloid Leukemia Patients in Chronic Phase with Sub-Optimal Response or Failure with Imatinib 400 Mg.

Katia BB Pagnano, MD, PhD, Marcia T Delamain, MD, Eliana C.M. Miranda, M.Ed, Vagner O Duarte, Brunna Eulálio Alves, MD, Carmino Antonio De Souza, MD, PhD, Irene Lorand-Metze, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3289.
https://doi.org/10.1182/blood.V114.22.3289.3289
Published: 2009